ONC compared with ABCL: revenue, margins and what each company keeps, and the suppliers and customers both name

ONCBeOne Medicines Ltd.

Mkt capRevenueRevenue

ABCLAbCellera Biologics Inc.

Mkt capRevenueRevenue

Compare

ONCBeOne Medicines Ltd.

ABCLAbCellera Biologics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ONC1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−0.15%—

ABCL1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.4%▲+10.30%×0.67

= impliedONC realized, solidABCL realized, hatchedOne scale, both sides: full bar = 16%× = |realized| ÷ impliedSource: market data

ONCBeOne Medicines Ltd.

365.70▼−1.58%· post 370.37

Mkt cap$42.1BRevenue$1.7BQ2 FY26Revenue$5.3BFY25

ABCLAbCellera Biologics Inc.

12.26▼−6.27%· post 12.22

ClosedOct 30 '26

Mkt cap$3.8BRevenue$4MQ2 FY26Revenue$75MFY25

Compare

ClosedOct 30 '26

ONCBeOne Medicines Ltd.

ABCLAbCellera Biologics Inc.

365.70▼−1.58%post 370.37

Price

12.26▼−6.27%post 12.22

$42.1B

Mkt cap

$3.8B

Q2 FY26$1.7B

Revenue

$4MQ2 FY26

FY25$5.3B

Revenue

$75MFY25

ONC365.70▼−1.58%vsABCL12.26▼−6.27%ClosedOct 30 '26